HomeMAP • ASX
Microba Life Sciences Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 4.04M | 147.01% |
Operating expense | 7.42M | -5.40% |
Net income | -2.87M | 50.02% |
Net profit margin | -71.02 | 79.77% |
Earnings per share | — | — |
EBITDA | -4.77M | 28.09% |
Effective tax rate | 2.37% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.45M | -37.77% |
Total assets | 50.79M | -22.15% |
Total liabilities | 15.10M | -5.57% |
Total equity | 35.69M | — |
Shares outstanding | 447.85M | — |
Price to book | 2.56 | — |
Return on assets | -27.09% | — |
Return on capital | -35.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.87M | 50.02% |
Cash from operations | -1.34M | 76.92% |
Cash from investing | -664.06K | 88.24% |
Cash from financing | 170.74K | -98.16% |
Net change in cash | -1.79M | 14.87% |
Free cash flow | -2.89M | 37.76% |
Previous close
$0.21
Day range
$0.21 - $0.22
Year range
$0.14 - $0.33
Market cap
94.00M AUD
Avg Volume
235.13K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
About
Founded
2017
Website
